Panagiotis Christoforou: Proud to Contribute to Barts Health’s Leading Role in UK Clinical Trials
Panagiotis Christoforou, Senior Research Fellow at Barts Health NHS Trust, shared Barts Health NHS Trust’s post on LinkedIn:
“Proud, as a Haematologist, to have been part of this achievement and to have contributed as a Clinical Research Fellow to Non-malignant haematology clinical trials at the Royal London Hospital.
It has been a privilege to work alongside such a dedicated multidisciplinary team, helping bring innovative treatments and new opportunities to our patients.”
Barts Health NHS Trust shared a post on LinkedIn:
“We’re the UK’s top recruiter to clinical trials.
More than 20,000 patients took part in research across our hospitals last year, helping advance healthcare for future generations.
For the seventh year running, we’ve recruited more patients to commercial drug trials than any other NHS trust, giving patients access to pioneering treatments and the latest innovations in care.
It’s all part of our commitment to delivering outstanding patient care through research, innovation and clinical excellence”
Other posts featuring Panagiotis Christoforou on Hemostasis Today.
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial